Long-term Impact Evaluation of a Worksite-based Lifestyle Intervention to Reduce Cardiovascular Risk in Office Workers

Summary

The main objective of TANSNIP-PESA is to determine in a population of asymptomatic bank employees with high and low imaging defined cardiovascular disease (CVD) risk the effectiveness of a comprehensive 3-year worksite-based lifestyle intervention consisting of 12 personalized lifestyle counseling sessions, a Fitbit physical activity tracker and a sit-stand Workstation.

Conditions

• Atherosclerosis

Interventions

BEHAVIORAL

Lifestyle intervention

1. Each participant will receive 12 personalized lifestyle counseling sessions given face-to-face by a trained practitioner. 2. The Fitbit physical activity tracker gives summaries of the participant's physical activity, provides stimulating prompts and rewards, and allows for social media sharing and competition. 3. A Sit-stand workstation allows to adjust the height of the participant workstation, including the computer screen, keyboard and mouse and allows them to easily switch between sitting and standing throughout the workday.

Sponsors & Collaborators

• Amsterdam UMC, location VUmc

  collaborator OTHER

• Instituto de Salud Carlos III

  collaborator OTHER_GOV

• Icahn School of Medicine at Mount Sinai

  collaborator OTHER

• Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

  lead OTHER

Principal Investigators

• Valentin Fuster, MD, PhD · Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

• Jose Maria Castellano, MD, PhD · Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

• Hidde van der Ploeg, PhD · Amsterdam UMC, location VUmc

• Willem van Mechelen, MD, PhD · Amsterdam UMC, location VUmc

• Borja Ibañez, MD, PhD · Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)

• Antonio Fernandez-Ortiz, MD, PhD · Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)

• Ines García Lunar, MD, PhD · Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

40 Years

Max Age

60 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2015-05-25

Primary Completion

2020-01-30

Completion

2020-01-30